The STEPS-EA trial is an ERNICA multi-centre randomised controlled trial looking at intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection.
Click here to access the latest STEPS-EA updates, via their newsletter (March 2021 issue)
If you have any questions regarding the STEPS-EA trial as a parent, patient or medical professional, please contact steps.ea@erasmusmc.nl
The team are more than happy to help you, or include you.
The STEPS–EA trial: intralesional STEroid injections to Prevent refractory Strictures in patients with Esophageal Atresia.
For more information about the STEPS-EA trial, you can watch the explainer video on ERNICA YouTube channel.
We comply with the HONcode standard for health trustworthy information
We are grateful for the financial support of EAT website
The 7th international Conference on EA will be held in Istambul, Turkey, in 2025.